Peter H.M. Bovendeerd is an Assistant Professor in the Department of Biomedical Engineering at Eindhoven University of Technology (TU/e), specializing in the Cardiovascular Biomechanics research group. He holds affiliations with the Eindhoven MedTech Innovation Center and EAISI Health. His work focuses on developing mathematical models to interpret clinical patient data, particularly in cardiac electromechanics, perioperative monitoring, and perinatal monitoring, collaborating with Catharina Hospital and Máxima Medical Center. Academically, Bovendeerd earned his MSc in Applied Physics (cum laude, 1985) and PhD (1990) from TU/e and Maastricht University, respectively. His research integrates fundamental physical/physiological principles to estimate pathologies from patient data through inverse modeling, aiding diagnosis and treatment planning. He teaches courses including Biomechanics, Cardiac Function, and Continuum Mechanics. Recent research emphasizes fetal blood circulation modeling, cardiac mechanics frameworks, and post-infarct ventricular function. His work contributes to UN Sustainable Development Goals through advancements in healthcare technology and innovation.
Antonios Pantazis is an Associate Professor and Docent at Linköping University, affiliated with the Department of Biomedical and Clinical Sciences (BKV) within the Faculty of Medicine and Health Sciences. He leads the Pantazis Laboratory of Cellular Excitability (PaLaCE), focusing on ion channel biophysics and their role in health and disease. His work integrates electrophysiological, optical, and computational methods to study ion channel structure-function relationships, particularly in cardiac and neuronal systems. Research interests include voltage-gated ion channels, cellular excitability, and the molecular mechanisms underlying arrhythmias and neurological disorders. Key contributions involve understanding mutations in genes like SCN5A and KCNA2, which are linked to epilepsy and cardiac arrhythmias. He has been awarded the Swedish Fernström Prize (2021) for his work on ion channels. Publications span topics such as ion channel regulation, molecular transitions in voltage-dependent processes, and drug targets for arrhythmia suppression. His laboratory also explores cutting-edge techniques like voltage-clamp fluorometry and optical methods to visualize protein dynamics. Collaborations include institutions like the Wallenberg Centre for Molecular Medicine (WCMM) at Linköping University, emphasizing translational research in medical technology and bioengineering.
David D. McManus, MD , is the Chair and Professor of Medicine at UMass Chan Medical School , where he also holds the Richard M. Haidack Professor in Medicine endowed title. He is affiliated with multiple departments across T.H. Chan School of Medicine and Morningside Graduate School of Biomedical Sciences , including Cardiovascular Medicine, Population and Quantitative Health Sciences, and Clinical Investigation. Education: Brown University – BS in Biological Sciences University of Massachusetts Medical School – MD University of Massachusetts Medical School – MS in Clinical Investigation Research Interests: McManus is a leading figure in cardiovascular medicine and digital health innovation . His research spans atrial fibrillation screening and management , wearable device validation , home-based cardiac monitoring , stroke prevention , hypertension , and population health informatics . He leads large-scale trials such as the GUARD-AF and VITAL-AF studies, evaluating the utility of wearable ECG devices in detecting undiagnosed atrial fibrillation. His work also includes COVID-19 diagnostics , digital therapeutics , and AI applications in cardiology . Scientific Awards & Recognition: While specific awards are not listed, McManus's prolific publication record and leadership roles in national and international trials underscore his prominence in cardiovascular and digital health research. Grants & Funding: He has received funding from NIH and other major bodies for trials such as GUARD-AF, VITAL-AF, and digital health interventions for stroke survivors and COPD patients. Labs & Teams: McManus leads interdisciplinary teams across UMass Medical School, collaborating with experts in cardiology, data science, behavioral science, and health informatics. His work integrates clinical research with real-world digital health implementation.
Eirik Skogvoll is a Professor at NTNU (Norwegian University of Science and Technology) and a pediatric anesthesiologist at St. Olav's University Hospital. He holds a leadership role as Vice Head for Research in the ISB Research group within the Faculty of Medicine and Health Sciences. His primary affiliation is with the Department of Circulation and Medical Imaging. Skogvoll's academic background includes an MD (1985), PhD (2000), and certifications in anesthesiology (1993) and pediatrics (2005). He has been actively involved in clinical work, teaching, and research at NTNU since 1994. Notably, he served as Head of the Resuscitation Committee at St. Olav's Hospital from 2008 to 2019 and was a visiting professor at the University of Pennsylvania in 2017. His research focuses on anesthesiology, emergency medicine, and cardiopulmonary resuscitation (CPR), with a particular emphasis on clinical circulatory physiology and medical statistics. He leads the Norwegian Cardiac Arrest Registry and has contributed to courses like Pediatric Emergencies and Medical Statistics in Clinical Analysis. Recent articles highlight advancements in AI-driven diagnostics (e.g., deep learning for ECG analysis), optimization of CPR techniques, and pediatric cardiac arrest epidemiology. His work bridges clinical practice and technological innovation, aiming to improve patient outcomes in critical care scenarios.
Dr. Fadi Gabriel Akar is a Professor of Medicine (Cardiovascular Medicine) and Biomedical Engineering at Yale University School of Medicine. He holds affiliations with the Cardiovascular Medicine Department, the Yale Cardiovascular Research Center, and the Molecular Medicine Program. His primary appointment is as a Professor in the Department of Medicine, specializing in cardiovascular research and translational medicine. Dr. Akar’s research focuses on unraveling mechanisms promoting arrhythmias in structural heart diseases and developing gene-based therapies to prevent malignant arrhythmias. His lab investigates mitochondrial dysfunction, metabolic signaling, and mechano-electrical feedback in arrhythmogenesis, with a translational pipeline from target identification to pre-clinical testing in large animal models. Key areas include arrhythmias in heart failure, myocardial infarction, obesity, diabetes, atrial fibrillation, and pulmonary hypertension. Notable achievements include his role as Chairman of the AHA Cardiac Electrophysiology Fellowships Committee (2022). His work bridges basic science and clinical applications, emphasizing mechanism-based therapies over traditional antiarrhythmic approaches. Collaborations include studies on AMPK deletion models, mitochondrial network remodeling, and resolvin D1’s role in post-MI atrial remodeling. Publications highlight contributions to understanding arrhythmia mechanisms in metabolic diseases, mitochondrial dysfunction, and translational therapies. His research is supported by NIH grants and industry partnerships, focusing on advancing diagnostics and treatments for electrical cardiac disorders.
Shuang Qian is an active academic researcher specializing in cardiac electrophysiology and computational medicine. Her work focuses on developing advanced digital twin technologies for heart disease analysis, leveraging machine learning and medical imaging (e.g., MRI) to model cardiac functions and arrhythmias. She contributes to the UN Sustainable Development Goals related to health and well-being through her research. Her research interests include optimizing anti-tachycardia pacing therapies, non-invasive localization of ventricular tachycardia exit sites, and improving treatment strategies for ischemic heart disease and repolarization abnormalities. She collaborates extensively with global teams on porcine heart models and has pioneered computational platforms using ECG and intracardiac data to guide clinical interventions. Shuang Qian’s publications highlight innovative approaches in cardiac modeling and virtual studies, with notable contributions to Nature Cardiovascular Research , EP Europace , and Computers in Biology and Medicine . While no specific scientific awards are listed, her work has been cited 24 times and garnered significant attention from news outlets and academic platforms like Mendeley. No information on advising students or grants is explicitly provided in the text. She is part of collaborative networks exploring cardiac electrophysiology, involving researchers like Mark Bishop, Santiago Monaci, and collaborators from the UK Biobank project. Her studies often integrate in-silico simulations, deep learning, and clinical device data to advance heart disease treatment methodologies.
Irene del Canto Serrano is a Researcher in the Department of Electronic Engineering at the School of Engineering, Universitat de València. Her work integrates biomedical engineering with cardiac electrophysiology, focusing on the interaction between mechanical forces and electrical activity in the heart. She is actively involved in two key research groups: GRELCA (Cardiac Electrophysiology group) and i2N (Electronic Instrumentation in Medical and Nuclear Physics), reflecting her dual expertise in physiology and instrumentation. Education: PhD in Biomedical Engineering, Universitat Politècnica de València (2015). Thesis: Estudio de las modificaciones farmacológicas de los efectos electrofisiológicos producidos por el estiramiento local miocárdico a partir de técnicas dinámicas de cartografía eléctrica, en un modelo experimental de corazón aislado de conejo , supervised by Dr. David Moratal Pérez and Dr. Francisco Javier Chorro Gascó. Her research interests center on cardiac electrophysiology , particularly mechanoelectric feedback , myocardial stretch , arrhythmia mechanisms , and pharmacological modulation using experimental models. She also explores cardiac imaging , especially cardiac MRI for strain and deformation analysis, and applies machine learning to improve detection and classification in myocardial infarction. Her recent publications highlight a strong trend toward integrating biomarkers (e.g., ferritin), iron therapy , and cardiac function recovery in heart failure, showing translational relevance. Her 15 most recent publications reflect a consistent focus on experimental cardiology using isolated heart models, pharmacological interventions (ranolazine, GS967, eleclazine), and advanced imaging techniques. She investigates how drugs affect stretch-induced arrhythmias, evaluates MRI-based strain changes post-iron therapy, and develops AI tools for cardiac image analysis. These works span basic science (e.g., CaMKII inhibition) to clinical applications (e.g., Myocardial-IRON trial analysis). Scientific Awards: No scientific awards mentioned in the provided text. Advising and Grants: While no formal students or grants are listed, her role as a postdoctoral researcher and active publication record suggest involvement in mentoring junior researchers and contributing to funded projects, particularly within the GRELCA and i2N groups. She has co-authored numerous experimental studies, indicating strong collaborative and project-based research activity. Labs and Teams: Irene is affiliated with two prominent research groups at Universitat de València: GRELCA (Cardiac Electrophysiology group) , which studies arrhythmia mechanisms and therapeutic interventions, and i2N (Electronic Instrumentation in Medical and Nuclear Physics) , which develops advanced tools for medical diagnostics. These affiliations underscore her interdisciplinary approach, combining physiology, engineering, and data science.
Professor Martin Graves is Professor of Magnetic Resonance Physics at the University of Cambridge, holding appointments within the School of Clinical Medicine and Department of Radiology. Since 1996, he has led the MRI Physics group at Addenbrooke's Hospital in Cambridge and serves as Honorary Consultant Clinical Scientist for the NHS. His primary institutional affiliation is with the Cambridge Mathematics of Information in Healthcare (CMIH) Hub at the Centre for Mathematical Sciences. His research focuses on advanced magnetic resonance imaging techniques with particular emphasis on hyperpolarized carbon-13 MRI for metabolic imaging applications. Key research areas include cardiac imaging for myocardial infarction assessment, cancer metabolism studies in renal cell carcinoma and ovarian cancer, neuroimaging of brain metabolism, and development of quantitative MRI methodologies. His work bridges physics, clinical medicine, and computational analysis to address diagnostic challenges in cardiovascular disease, oncology, and neurology. Analysis of his recent publications (2021-2025) reveals strong trends in hyperpolarized pyruvate imaging for cancer treatment monitoring, radiomics for plaque vulnerability assessment, and technical innovations in zero echo-time MRI. His research consistently targets clinical translation of advanced MRI techniques, with substantial focus on quantitative biomarkers for early treatment response assessment. No scientific awards or honors are documented in the provided materials Graves maintains active clinical-academic integration through his NHS consultancy role while leading physics research within Cambridge's imaging infrastructure. His work demonstrates consistent collaboration across medical specialties including cardiology, oncology, and neurology, with emphasis on developing clinically viable quantitative imaging biomarkers. The CMIH Hub serves as his primary research platform for mathematical approaches to healthcare imaging challenges.
Shaun M. Chatelain, DO, serves as a Clinical Assistant Professor in the Department of Internal Medicine at the University of Utah School of Medicine, providing specialized geriatric care at Sugarhouse Health Center and Madsen Health Center clinics in Salt Lake City. His academic training includes: Undergraduate: B.S. in Biological Engineering (minor in Chemistry) from Utah State University Medical Degree: Doctor of Osteopathic Medicine from Arizona College of Osteopathic Medicine Residency: Internal Medicine at the University of Arizona Fellowship: Geriatrics at the University of Utah Dr. Chatelain's clinical expertise centers on geriatric medicine with specialized focus on bone health and osteoporosis management , geriatric behavioral health , and deprescribing strategies for polypharmacy . His patient-centered approach emphasizes learning from older adults while optimizing medication regimens to enhance quality of life. His scholarly work (2015-2025) demonstrates consistent contributions to geriatric pharmacotherapy, with recurring themes in medication safety, preoperative assessment for elderly patients, and depression management. Notably, his textbook chapters in Pharmacotherapy: Principles and Practice have established him as a thought leader in evidence-based geriatric care protocols.
Sune Damgaard is a Clinical Associate Professor at the University of Copenhagen's Faculty of Health and Medical Sciences within the Department of Clinical Medicine. He specializes in Cardiothoracic Surgery at Rigshospitalet (Copenhagen University Hospital), where he maintains active clinical and research roles. His academic profile is associated with the Department of Clinical Medicine and Rigshospitalet's Heart and Lung Surgery division. Dr. Damgaard's research focuses on expanding traditional cardiac surgery risk assessment models beyond physiological parameters. His work investigates how social, emotional, behavioral, and functional factors impact surgical outcomes. Key areas include validating modified EuroSCORE systems, developing multidimensional risk prediction tools, and studying echocardiographic techniques during cardiac procedures. He has pioneered research on tricuspid annular plane systolic excursion measurement and coronary bypass graft patency assessment. His publication trends reveal consistent emphasis on integrating patient-reported outcomes into surgical risk models. Recent work (2018-2022) demonstrates growing focus on psychosocial predictors of cardiac surgery outcomes, with multiple studies examining how non-physiological factors contribute to postoperative complications. Earlier research (2012-2015) centered on technical aspects of graft patency and intraoperative monitoring. Dr. Damgaard maintains active clinical practice at Rigshospitalet's Cardiothoracic Surgery department while conducting translational research through the University of Copenhagen's medical faculty. His work bridges clinical cardiology, surgical innovation, and health services research with particular relevance to improving risk stratification in cardiac surgery.
Edward G. Grant, MD, serves as a Clinical Professor of Radiology (Part-Time) at the University of Southern California (USC), where he was Chair of the Department of Radiology from 2002 to 2019. Prior to USC, he chaired the Imaging Department at Greater Los Angeles VA Healthcare System and held professorial and vice-chair positions at UCLA. His career spans over three decades in academic radiology with a focus on clinical ultrasound innovation and leadership. Dr. Grant is an internationally recognized authority in ultrasound, having pioneered neonatal cranial sonography early in his career. His research encompasses Doppler ultrasound for vascular disease diagnosis, clinical investigation of ultrasound contrast agents, PACS, and advancements in thyroid and liver imaging. He has authored four books and numerous peer-reviewed articles, establishing himself as a leading figure in diagnostic radiology. Analysis of his 15 most recent publications (2021-2025) reveals a strong emphasis on contrast-enhanced ultrasound applications across multiple organ systems, particularly in thyroid nodule characterization (TI-RADS), liver disease quantification, and renal transplant evaluation. His work also addresses emerging areas like AI integration in ultrasound reporting and environmental impacts on fetal development through the MADRES cohort study. His notable awards include: Pasadena Magazine Top Doctor (2011) Dr. Grant has served as an examiner for the American Board of Radiology for 13 consecutive years and remains an active lecturer at national and international conferences. While the provided text does not detail specific grants or student advising, his extensive publication record and leadership roles indicate significant contributions to radiology education and clinical practice advancement.
Dr. Peter Swoboda is an honorary Associate Professor in Cardiology at the University of Leeds and a consultant cardiologist. His research focuses on the interplay between exercise and cardiac disease, particularly in aging populations, funded by the British Heart Foundation. He also investigates advancements in heart failure diagnosis and treatment. Clinically, he specializes in cardiac imaging, leading the cardiac MRI service at Mid Yorkshire Teaching Hospitals Trust and serving on the British Society for Cardiovascular Magnetic Resonance (BSCMR) board. His research portfolio includes studies on myocardial fibrosis in endurance athletes, arrhythmia risk in veteran athletes, and the diagnostic utility of 4D flow MRI. He leads the CE-MARC 3 trial, evaluating cost-effective approaches to stable chest pain management. Over 15 peer-reviewed articles from 2025–2023 highlight his work in cardiac imaging, ischemia, and post-COVID cardiac involvement. No scientific awards are listed. His clinical roles include overseeing MRI services and contributing to national cardiovascular imaging guidelines. He actively collaborates on studies involving cardiac mechanics, genetics of cardiomyopathy, and exercise physiology impacts on cardiac structure.
Clinical Professor Anthony McLean is affiliated with the Department of Intensive Care Medicine at the Nepean Clinical School, University of Sydney, within the Faculty of Medicine and Health. His research focuses on critical care echocardiography, sepsis, cardiovascular diseases, infection and immunity, and translational research. He has contributed to international guidelines for managing sepsis and septic shock, and has been involved in developing training standards for critical care ultrasound competency. Key research areas include biomarker identification for respiratory infections (e.g., IFI27), hemodynamic monitoring in critically ill patients, and the role of genetics and genomic signatures in sepsis and influenza pathogenesis. McLean has authored/co-authored major textbooks such as the 2020 Oxford Textbook of Advanced Critical Care Echocardiography and the 2012 Critical Care Ultrasound Manual , and has led studies on fluid therapy optimization, beta-blocker effects in sepsis, and post-partum catastrophic antiphospholipid syndrome. Hosted the ECHO-COVID multinational study analyzing echocardiography findings in ICU patients Co-developed the PRICES statement guiding critical care echocardiography research reporting Contributed to Surviving Sepsis Campaign international guidelines (2016) Explored molecular mechanisms linking metabolic pathways to critical illness outcomes His work emphasizes bridging clinical practice and research through translational approaches, with a focus on improving diagnostic accuracy and patient management in intensive care settings. He has collaborated extensively with organizations like the European Society of Intensive Care Medicine (ESICM) and the College of Intensive Care Medicine (CICM) to establish training frameworks and competency standards.
LLewelyn Roderick is a full professor at the Department of Cardiovascular Sciences , Faculty of Medicine, KU Leuven. He leads the Experimental Cardiology unit and contributes to doctoral committees and faculty governance. Research focuses on calcium signaling microdomains, epigenetic regulation of cardiac growth, and arrhythmogenesis mechanisms. Projects include studies on obesity-induced cardiomyocyte dysfunction, hypoxia sensitivity in cardiac cells, and DNA methylation in aging hearts. Current initiatives investigate connexin-43 hemichannels, neutrophil extracellular traps, and 3D cardiac models for drug discovery. His work spans fundamental cardiovascular biology and translational approaches, including collaborations on immune-monitoring technologies and cardiac progenitor cell metabolism. Teaching contributions include advanced courses on epigenetics and cardiovascular biology.
Lisa Qia Rong is an Associate Professor of Anesthesiology at Weill Cornell Medical College and an Associate Attending Anesthesiologist at NewYork-Presbyterian Hospital. Her clinical and academic work is centered on cardiovascular anesthesiology, with a focus on intraoperative echocardiography and perioperative outcomes in cardiac surgery. Associate Professor, Department of Anesthesiology, Weill Cornell Medical College Associate Attending Anesthesiologist, NewYork-Presbyterian Hospital Principal Investigator, NHLBI-funded research on surgical revascularization Education: B.A., Columbia University, 2005 M.D., Robert Wood Johnson Medical School, 2009 M.Sc., Weill Cornell Graduate School of Medical Sciences, 2021 Residency: NYU Langone Medical Center Fellowship: University of Washington Medical Center Dr. Rong’s research focuses on cardiovascular anesthesiology , particularly the use of 3D transesophageal echocardiography in guiding structural heart interventions and assessing myocardial function. She investigates perioperative outcomes , including atrial fibrillation, renal injury, and disparities in care based on sex, insurance status, and socioeconomic factors. Her work also emphasizes methodological rigor, authorship equity, and the integrity of medical literature, including retracted studies. Her recent publications (2023–2025) show a strong trend in intraoperative imaging , evidence-based guidelines , and healthcare disparities . She frequently contributes to high-impact journals such as Circulation , JACC , and British Journal of Anaesthesia , with a focus on echocardiographic validation, meta-analyses, and scientific statements. Her research bridges clinical practice with academic scholarship, particularly in optimizing cardiac surgical outcomes through advanced imaging and equitable care delivery. Scientific Awards: No awards listed in the provided text. Dr. Rong serves as Principal Investigator on an NHLBI-funded project examining the impact of surgical revascularization strategies on left ventricular function and clinical outcomes (2021–2026). She has no reported external relationships. She advises on methodological quality in guidelines and has published on authorship patterns, gender disparities, and research integrity, contributing to academic discourse beyond direct clinical research. She is actively involved in research networks such as the ROMA trial network and has contributed to large-scale analyses on TAVR, pericardiotomy, and pulmonary artery catheter use. Her work often involves collaboration across institutions and disciplines, reflecting a systems-level approach to improving cardiovascular care.
